Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 3
1961 3
1962 2
1963 18
1964 12
1965 13
1966 4
1967 11
1968 12
1969 14
1970 13
1971 18
1972 23
1973 30
1974 27
1975 33
1976 26
1977 39
1978 28
1979 38
1980 36
1981 29
1982 27
1983 45
1984 42
1985 37
1986 33
1987 30
1988 32
1989 27
1990 41
1991 25
1992 34
1993 24
1994 26
1995 28
1996 36
1997 24
1998 30
1999 20
2000 20
2001 25
2002 33
2003 24
2004 39
2005 45
2006 37
2007 40
2008 22
2009 31
2010 31
2011 41
2012 40
2013 39
2014 32
2015 37
2016 29
2017 44
2018 36
2019 47
2020 37
2021 30
2022 31
Text availability
Article attribute
Article type
Publication date

Search Results

1,694 results
Results by year
Filters applied: . Clear all
Page 1
[Ethosuximide].
Ichiba M, Kitazawa S. Ichiba M, et al. Nihon Rinsho. 1995 Feb;53 Su Pt 1:915-7. Nihon Rinsho. 1995. PMID: 8753586 Review. Japanese. No abstract available.
The metabolism of ethosuximide.
Millership JS, Mifsud J, Collier PS. Millership JS, et al. Eur J Drug Metab Pharmacokinet. 1993 Oct-Dec;18(4):349-53. doi: 10.1007/BF03190184. Eur J Drug Metab Pharmacokinet. 1993. PMID: 8020533 Review.
The metabolism of the antiepileptic drug ethosuximide (3-ethyl-3-methylpyrollidine-2,5-dione) (I) in animals and humans is reviewed. Chiral aspects of the metabolism of ethosuximide are discussed. Clarification of the precise nature of the hydroxymetabolites of e
The metabolism of the antiepileptic drug ethosuximide (3-ethyl-3-methylpyrollidine-2,5-dione) (I) in animals and humans is reviewed. …
Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
Brigo F, Igwe SC, Lattanzi S. Brigo F, et al. Cochrane Database Syst Rev. 2021 Jan 21;1(1):CD003032. doi: 10.1002/14651858.CD003032.pub5. Cochrane Database Syst Rev. 2021. PMID: 33475151 Free PMC article.
Due to the differing methodologies used in the trials comparing ethosuximide, lamotrigine and valproate, we thought it inappropriate to undertake a meta-analysis. One large randomised, parallel double-blind controlled trial comparing ethosuximide, lamotrigine and so …
Due to the differing methodologies used in the trials comparing ethosuximide, lamotrigine and valproate, we thought it inappropriate …
Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
Brigo F, Igwe SC. Brigo F, et al. Cochrane Database Syst Rev. 2017 Feb 14;2(2):CD003032. doi: 10.1002/14651858.CD003032.pub3. Cochrane Database Syst Rev. 2017. PMID: 28195639 Free PMC article. Updated. Review.
Due to the differing methodologies used in the trials comparing ethosuximide, lamotrigine and valproate, we thought it inappropriate to undertake a meta-analysis. One large randomised, parallel double-blind controlled trial comparing ethosuximide, lamotrigine and so …
Due to the differing methodologies used in the trials comparing ethosuximide, lamotrigine and valproate, we thought it inappropriate …
Ethosuximide: from bench to bedside.
Gören MZ, Onat F. Gören MZ, et al. CNS Drug Rev. 2007 Summer;13(2):224-39. doi: 10.1111/j.1527-3458.2007.00009.x. CNS Drug Rev. 2007. PMID: 17627674 Free PMC article. Review.
Commonly observed side effects of ethosuximide are dose dependent and involve the gastrointestinal tract and central nervous system. Ethosuximide has been associated with a wide variety of idiosyncratic reactions and with hematopoietic adverse effects. ...
Commonly observed side effects of ethosuximide are dose dependent and involve the gastrointestinal tract and central nervous system. …
Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.
Glauser TA, Cnaan A, Shinnar S, Hirtz DG, Dlugos D, Masur D, Clark PO, Capparelli EV, Adamson PC; Childhood Absence Epilepsy Study Group. Glauser TA, et al. N Engl J Med. 2010 Mar 4;362(9):790-9. doi: 10.1056/NEJMoa0902014. N Engl J Med. 2010. PMID: 20200383 Free PMC article. Clinical Trial.
CONCLUSIONS: Ethosuximide and valproic acid are more effective than lamotrigine in the treatment of childhood absence epilepsy. Ethosuximide is associated with fewer adverse attentional effects. (ClinicalTrials.gov number, NCT00088452.)...
CONCLUSIONS: Ethosuximide and valproic acid are more effective than lamotrigine in the treatment of childhood absence epilepsy. Et
Absence seizures in children.
Posner E. Posner E. BMJ Clin Evid. 2013 Dec 18;2013:0317. BMJ Clin Evid. 2013. PMID: 24351614 Free PMC article. Review.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: clonazepam, ethosuximide, gabapentin, lamotrigine, and valproate....
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: clona …
Ethosuximide induced macroglossia and oropharyngeal edema.
Shang H, Glaun M, Ongkasuwan J. Shang H, et al. Int J Pediatr Otorhinolaryngol. 2021 Jan;140:110498. doi: 10.1016/j.ijporl.2020.110498. Epub 2020 Nov 15. Int J Pediatr Otorhinolaryngol. 2021. PMID: 33218689
We report a case of acute macroglossia that began after initiation of ethosuximide in a 15-year-old female with severe medically refractory epilepsy. Macroglossia worsened over the next two weeks of ethosuximide administration, preventing extubation. Macroglossia an …
We report a case of acute macroglossia that began after initiation of ethosuximide in a 15-year-old female with severe medically refr …
Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
Posner EB, Mohamed K, Marson AG. Posner EB, et al. Cochrane Database Syst Rev. 2003;(3):CD003032. doi: 10.1002/14651858.CD003032. Cochrane Database Syst Rev. 2003. PMID: 12917940 Updated. Review.
We also contacted Sanofi Winthrop, Glaxo Wellcome (now GlaxoSmithKline) and Parke Davis (now Pfizer), manufacturers of sodium valproate, lamotrigine and ethosuximide respectively. SELECTION CRITERIA: Randomised parallel group monotherapy or add-on trials which include a co …
We also contacted Sanofi Winthrop, Glaxo Wellcome (now GlaxoSmithKline) and Parke Davis (now Pfizer), manufacturers of sodium valproate, lam …
1,694 results